Literature DB >> 28744981

The concordance between self-reported medication use and pharmacy records in pregnant women.

K Cheung1,2, H El Marroun1,3,4, M E Elfrink5, V W V Jaddoe1,4, L E Visser1,6, B H Ch Stricker1,2.   

Abstract

PURPOSE: Several studies have been conducted to assess determinants affecting the performance or accuracy of self-reports. These studies are often not focused on pregnant women, or medical records were used as a data source where it is unclear if medications have been dispensed. Therefore, our objective was to evaluate the concordance between self-reported medication data and pharmacy records among pregnant women and its determinants.
METHODS: We conducted a population-based cohort study within the Generation R study, in 2637 pregnant women. The concordance between self-reported medication data and pharmacy records was calculated for different therapeutic classes using Yule's Y. We evaluated a number of variables as determinant of discordance between both sources through univariate and multivariate logistic regression analysis.
RESULTS: The concordance between self-reports and pharmacy records was moderate to good for medications used for chronic conditions, such as selective serotonin reuptake inhibitors or anti-asthmatic medications (0.88 and 0.68, respectively). Medications that are used occasionally, such as antibiotics, had a lower concordance (0.51). Women with a Turkish or other non-Western background were more likely to demonstrate discordance between pharmacy records and self-reported data compared with women with a Dutch background (Turkish: odds ratio, 1.63; 95% confidence interval, 1.16-2.29; other non-Western: odds ratio, 1.33; 95% confidence interval, 1.03-1.71).
CONCLUSIONS: Further research is needed to assess how the cultural or ethnic differences may affect the concordance or discordance between both medication sources. The results of this study showed that the use of multiple sources is needed to have a good estimation of the medication use during pregnancy.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  concordance; determinants; medication; pharmacy record; pregnancy; self-report

Mesh:

Substances:

Year:  2017        PMID: 28744981     DOI: 10.1002/pds.4264

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  Interaction between Maternal Immune Activation and Antibiotic Use during Pregnancy and Child Risk of Autism Spectrum Disorder.

Authors:  Calliope Holingue; Martha Brucato; Christine Ladd-Acosta; Xiumei Hong; Heather Volk; Noel T Mueller; Xiaobin Wang; M Daniele Fallin
Journal:  Autism Res       Date:  2020-10-16       Impact factor: 5.216

2.  POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure.

Authors:  Justine Benevent; Caroline Hurault-Delarue; Mélanie Araujo; Jean-Louis Montastruc; Isabelle Lacroix; Christine Damase-Michel
Journal:  Drug Saf       Date:  2019-01       Impact factor: 5.606

3.  Quantification of selection bias in studies of risk factors for birth defects among livebirths.

Authors:  Dominique Heinke; Janet W Rich-Edwards; Paige L Williams; Sonia Hernandez-Diaz; Marlene Anderka; Sarah C Fisher; Tania A Desrosiers; Gary M Shaw; Paul A Romitti; Mark A Canfield; Mahsa M Yazdy
Journal:  Paediatr Perinat Epidemiol       Date:  2020-04-06       Impact factor: 3.103

4.  Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data.

Authors:  Rebecca M Joseph; Tjeerd P van Staa; Mark Lunt; Michal Abrahamowicz; William G Dixon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-09-28       Impact factor: 2.890

5.  Medication history-wide association studies for pharmacovigilance of pregnant patients.

Authors:  Anup P Challa; Xinnan Niu; Etoi A Garrison; Sara L Van Driest; Lisa M Bastarache; Ethan S Lippmann; Robert R Lavieri; Jeffery A Goldstein; David M Aronoff
Journal:  Commun Med (Lond)       Date:  2022-09-16

6.  Drug prescribing during pregnancy in a central region of Italy, 2008-2012.

Authors:  Martina Ventura; Alice Maraschini; Paola D'Aloja; Ursula Kirchmayer; Ilaria Lega; Marina Davoli; Serena Donati
Journal:  BMC Public Health       Date:  2018-05-15       Impact factor: 3.295

7.  Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.

Authors:  Jakob Christensen; Lars Pedersen; Yuelian Sun; Julie Werenberg Dreier; Isabell Brikell; Søren Dalsgaard
Journal:  JAMA Netw Open       Date:  2019-01-04

8.  Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.

Authors:  Christine Aarenstrup Daugaard; Lars Pedersen; Yuelian Sun; Julie Werenberg Dreier; Jakob Christensen
Journal:  JAMA Netw Open       Date:  2020-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.